- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on MDS-EB
Total 735 results
-
Nkarta Inc.Active, not recruitingMDS | AML, Adult | Relapsed/Refractory AML | Refractory Myelodysplastic SyndromesUnited States
-
Merck Sharp & Dohme LLCTerminatedDLBCL | AML Including AML de Novo and AML Secondary to MDS
-
Peking University People's HospitalCompletedAdvanced MDS Without Identical Sibling DonorChina
-
Prof. Janet DunnKing's College Hospital NHS Trust; University of Manchester; University of Birmingham and other collaboratorsRecruitingMyelodysplastic Syndromes (MDS)United Kingdom
-
AbbVieGenentech, Inc.Active, not recruitingMyelodysplastic Syndrome (MDS)United States, Australia, Austria, Belgium, Brazil, Canada, China, Czechia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Puerto Rico, Russian Federation, Spain, Taiwan, Turkey, United Kingdom, Hungary
-
Amphivena Therapeutics, Inc.CompletedMyelodysplastic Syndrome (MDS)United States
-
CelgeneCompletedMyelodysplastic Syndrome (MDS)China
-
Novartis PharmaceuticalsTerminatedMyelodysplastic Syndrome (MDS)Germany
-
TelikCompletedMyelodysplastic Syndrome (MDS)United States
-
Unity Health TorontoActive, not recruiting
-
Jason Robert GotlibCelgene CorporationTerminatedLeukemia | Anemia | Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML)United States
-
Case Comprehensive Cancer CenterRecruitingMyelodysplastic Syndrome (MDS)United States
-
Radboud University Medical CenterRecruitingMyelodysplastic Syndromes (MDS)Denmark, Switzerland, Serbia, Austria, Croatia, Czechia, France, Germany, Greece, Israel, Italy, Netherlands, Poland, Portugal, Romania, Spain, Sweden, United Kingdom
-
Novartis PharmaceuticalsTerminatedMyelodysplastic Syndrome (MDS)France, Spain, Belgium, Italy, Greece, Hungary, Germany
-
BioSight Ltd.Active, not recruitingRefractory Acute Myeloid Leukemia | MDS | AML, Adult | Relapse/RecurrenceUnited States
-
TakedaWithdrawn
-
Weill Medical College of Cornell UniversityNovartis PharmaceuticalsCompletedMyelodysplastic Syndrome (MDS)United States
-
Incyte CorporationTerminatedMDS (Myelodysplastic Syndrome)United States
-
Chinese Society of HematologyHarbin Institute of Hematology & OncologyUnknownMyelodysplastic Syndrome (MDS)
-
Asociación Andaluza de Hematología y HemoterapiaCompleted
-
Genzyme, a Sanofi CompanyTerminatedMyelodysplastic Syndrome (MDS)Germany, United Kingdom, France, Netherlands
-
Heinrich-Heine University, DuesseldorfTerminatedMyelodysplastic Syndrome MDSGermany
-
TelikTerminatedMyelodysplastic Syndrome (MDS)United States
-
TelikCompletedMyelodysplastic Syndrome (MDS)United States
-
Seagen Inc.CompletedMyelodysplastic Syndrome (MDS)United States
-
Harvard School of Public Health (HSPH)Boston University; Massachusetts General Hospital; Dana-Farber Cancer Institute; Brigham and Women's Hospital and other collaboratorsCompletedPhysical Activity | Sleep | Dietary Habits | Health Behavior | MSDsUnited States
-
St. Jude Children's Research HospitalActive, not recruitingB-ALL | T-ALL | AML/MDS | BPDCNUnited States
-
Sigilon Therapeutics, Inc.WithdrawnMPS I | MPS1-S | MPS1-HSBrazil, United Kingdom
-
Alshimaa AbdalkreemRecruiting
-
Sidney Kimmel Cancer Center at Thomas Jefferson...TerminatedHodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Acute Leukemia | Hematologic Malignancies | Myeloma | Myelodysplastic Syndromes (MDS) Other Than RA or RARS Subtypes | Chronic Myelogenous (or Myeloid) Leukemia (CML) Resistant to STI TherapyUnited States
-
AmgenCompletedMyelodysplastic Syndromes | Thrombocytopenia | MDS
-
AmgenCompletedMyelodysplastic Syndromes | Thrombocytopenia | MDS
-
Chinese PLA General HospitalNavy General Hospital, BeijingCompleted
-
AmgenCompletedMyelodysplastic Syndromes | Thrombocytopenia | MDS | Hematology
-
University of ZurichCompletedObstructed Defecation Syndrome (ODS)Switzerland
-
AmgenCompletedDetermination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS)Myelodysplastic Syndromes | Thrombocytopenia | MDS | Refractory Cytopenias
-
The First Affiliated Hospital with Nanjing Medical...Unknown
-
Senti BiosciencesRecruitingAML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological MalignanciesUnited States, Australia
-
H. Lee Moffitt Cancer Center and Research InstituteGlaxoSmithKlineTerminatedThrombocytopenia | Myelodysplastic Syndrome (MDS)United States
-
Tarix PharmaceuticalsTerminatedMyelodysplastic Syndrome (MDS)United States
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingSevere Aplastic Anemia | Single Lineage Cytopenias, T-LGL | Hypoplastic MDSUnited States
-
Research Foundation for Mental Hygiene, Inc.Terminated
-
University of Texas at AustinWithdrawn
-
Novartis PharmaceuticalsTerminatedThrombocytopaeniaUnited States, Belgium, Australia, Canada, Hong Kong, Austria, Brazil, Czechia, Israel, Russian Federation, Spain, Sweden, Thailand, Denmark, France, Germany, Ireland, Italy, Korea, Republic of, Peru, Switzerland, Taiwan, Turkey, Hungary and more
-
Forma Therapeutics, Inc.RecruitingVery Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-RUnited States, France, Canada, Germany
-
Seattle Children's HospitalChildren's Healthcare of Atlanta; Pediatric Oncology Experimental Therapeutics...CompletedAML | Acute Leukemia of Ambiguous Lineage | ALL | Relapsed/Refractory AML | Relapsed/Refractory ALL | Secondary AML/MDSUnited States, Canada
-
Onconova Therapeutics, Inc.CompletedMyelodysplastic Syndrome | MDS | Trisomy 8United States